Clinical efficacy and quality of life in a clinical trial comparing olanzapine and ziprasidone

被引：0
|
作者：
Van Brunt, DL
Namjoshi, M
Xu, W
Berg, PH
Roychowdhury, SM
Cavazzoni, P
Naber, D
Breier, A
机构：
[1] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA
[2] Univ Hamburg, Hamburg, Germany
来源：
SCHIZOPHRENIA RESEARCH | 2004年 / 67卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：177 / 178
页数：2
相关论文
共 50 条
  • [21] Drug attitudes and treatment adherence in a clinical trial comparing haloperidol and olanzapine in first episode schizophrenia
    Centorrino, F
    Hamer, RM
    Tohen, M
    Glick, ID
    McEvoy, JP
    Perkins, DO
    Sharma, T
    Zipursky, RM
    Kahn, R
    Gur, RE
    Green, AI
    Nemeroff, CB
    Rothschild, A
    Strakowski, SM
    Tollefson, GD
    Lieberman, JA
    BIOLOGICAL PSYCHIATRY, 2003, 53 (08) : 186S - 186S
  • [22] Efficacy of olanzapine: An overview of pivotal clinical trials
    Beasley, CM
    Tollefson, GD
    Tran, PV
    JOURNAL OF CLINICAL PSYCHIATRY, 1997, 58 : 7 - 12
  • [23] Plasma concentration of olanzapine and its clinical efficacy
    Sekiguchi, G
    Morokawa, Y
    Kumai, T
    Akimoto, T
    Nakaya, S
    Suzuki, H
    Gen, K
    Kobayashi, S
    Aoba, A
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2004, 19 (03) : 178 - 178
  • [24] Comparing efficacy of first-line atypical antipsychotics: no evidence of differential efficacy between risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole
    Tandon, R
    Jibson, MD
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2005, 9 (03) : 204 - 212
  • [25] Drug attitudes and treatment adherence in a clinical trial comparing haloperidol and olanzapine in first episode schizophrenia
    Centorrino, F
    Hamer, RM
    Tohen, M
    Lieberman, JA
    SCHIZOPHRENIA RESEARCH, 2003, 60 (01) : 277 - 277
  • [26] Economic, clinical, and quality-of-life outcomes associated with olanzapine treatment in mania - Results from a randomized controlled trial
    Namjoshi, MA
    Rajamannar, G
    Jacobs, T
    Sanger, TM
    Risser, R
    Tohen, MF
    Breier, A
    Keck, PE
    JOURNAL OF AFFECTIVE DISORDERS, 2002, 69 (1-3) : 109 - 118
  • [27] Olanzapine for developmental stuttering: A pilot clinical trial
    Riggs, GH
    Blindauer, K
    Hymes, E
    Jones, K
    Kurlan, RM
    NEUROLOGY, 2002, 58 (07) : A268 - A269
  • [28] Quality-of-Life Outcomes From a Randomized Clinical Trial Comparing Antimetabolites for Intermediate, Posterior, and Panuveitis
    Niemeyer, Katherine M.
    Gonzales, John A.
    Rathinam, Sivakumar R.
    Babu, Manohar
    Thundikandy, Radhika
    Kanakath, Anuradha
    Porco, Travis C.
    Browne, Erica N.
    Rao, Maya M.
    Acharya, Nisha R.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 179 : 10 - 17
  • [29] CLINICAL-TRIAL COMPARING RELATIVE EFFICACY OF 3 FLUORIDE DENTIFRICES
    BLINKHORN, AS
    KAY, EJ
    JOURNAL OF DENTAL RESEARCH, 1987, 66 : 216 - 216
  • [30] The contribution of etanercept: from clinical efficacy to quality of life
    Joly, Pascal
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2006, 133 (8-9): : S10 - S17
12345